跳到正文
GMP干货· 心作流云·· 20 天前AI 评分62

审计追踪审核问答(2):QA 与流程所有者职责、审核频率及记录方式

审计追踪审核问答(2)

AI 导读

GMP Journal 的审计追踪审核问答第二部分说明,审计追踪审核通常由生成数据的部门(如 QC 或生产)由同事执行同行审核,只需一名具备相应专业知识的人员,QA 不参与该次审核。

正文

本文原文来自GMP Journal网站,上一期问答见文章:审计追踪审核问答(1)。

Question 10: Who is the process owner for the Audit Trail review – QA or the system owner?

问题 10:审计追踪审核的流程所有者是谁——QA 还是系统所有者?

The Audit Trail Review is normally carried out by the department that generated the data (for example QC or production), but not by the same person who created the data – rather by a colleague (peer review). In the first FDA data integrity guidance, the quality unit (Quality Assurance) was still mentioned for this; this was later amended to require review by a function with appropriate expertise. All other guidance documents share this view.

审计追踪审核通常由生成数据的部门(例如 QC 或生产)执行,但不是由创建数据的同一人执行,而是由同事执行(同行审核)。在首版 FDA 数据完整性指南中,仍提到由质量部门(质量保证)负责此事;后来修改为要求由具备相应专业知识的职能进行审核。所有其他指南文件均持这一观点。

Question 11: Who is responsible for preparing the specific Audit Trail Review SOP – the process owner (e.g. Operations) or QA? And who must prepare an SOP on the general framework conditions for Audit Trail Review?

问题 11:谁负责制定具体的审计追踪审核 SOP——流程所有者(例如运营部门)还是 QA?谁必须制定关于审计追踪审核总体框架条件的 SOP?

To carry out Audit Trail Review, an SOP is first required which lays down, for the company, the risk assessment, responsibilities for conducting the review and the review frequency. This general SOP is usually prepared by the Quality Assurance department.

要执行审计追踪审核,首先需要一份 SOP,为公司规定风险评估、执行审核的职责以及审核频率。这份通用 SOP 通常由质量保证部门制定。

For carrying out Audit Trail Reviews in a specific computer system (for example a chromatography data system, CDS), the data fields to be reviewed must be defined in a checklist. This checklist is drawn up by the specialised department that operates the system.

要在特定计算机系统(例如色谱数据系统,CDS)中执行审计追踪审核,必须在检查清单中界定需要审核的数据字段。该检查清单由操作该系统的专业部门起草。

Question 12: Is there a regulatory basis for the risk-based definition of Audit Trail Review intervals and scope?

问题 12:基于风险确定审计追踪审核间隔和范围是否有监管依据?

Pharmaceutical regulations do not, in principle, require any specific method for determining risk. However, it is recommended to apply ICH Q9, which has been available in a new version since 2023. It sets out a whole range of methods that can be used as options; the method most commonly used in the pharmaceutical industry is FMEA, in which a numerical value is assigned to the estimated risk. Value ranges of 0–10 and 0–5 are most commonly used, although there is a preference for ranges of 0–4 or 0–6, where the mid-point is not used as the exact value for medium risk.

药品法规原则上不要求采用任何特定方法来确定风险。然而,建议应用 ICH Q9,该指南自 2023 年起已有新版本。它列出了一系列可作为选项使用的方法;制药行业最常用的方法是 FMEA,即对估计的风险赋予数值。最常用的数值范围为 0–10 和 0–5,不过也有偏好使用 0–4 或 0–6 范围的做法,其中中点不作为中等风险的精确值使用。

When defining intervals, it should be taken into account that initially all batches are reviewed, and that – after considering a long period of time (for example one year) – the review frequency can, where appropriate, be reduced. However, such a practice may lead to observations during an authority inspection.

在确定间隔时,应考虑到最初所有批次均需审核,并且在考虑较长一段时间(例如一年)后,审核频率可在适当情况下降低。然而,这种做法可能在监管检查中导致缺陷观察项。

Question 13: As a general rule, how is Audit Trail Review carried out: “by hand” by a member of staff or electronically supported?

问题 13:作为一般规则,审计追踪审核如何执行:由员工“手工”执行还是以电子方式支持?

In practice, the audit trail review is carried out in very different ways. In the laboratory, a specific checklist is usually used, which is finally commented on and signed by the reviewer. It is important that this checklist identifies all data fields to be checked in order to ensure a complete review. It is advisable to carry out the review on screen, in order to avoid time-consuming printing with subsequent filing/archiving of the documentation. The conduct of the audit trail review (responsibility, frequency, documentation) must be defined in an SOP.

在实践中,审计追踪审核的执行方式差异很大。在实验室中,通常使用特定的检查清单,最终由审核人评论并签字。重要的是,该检查清单应标识所有需要检查的数据字段,以确保审核完整。建议在屏幕上进行审核,以避免耗时打印以及随后对文件进行归档/存档。审计追踪审核的实施方式(职责、频率、记录)必须在 SOP 中加以规定。

Question 14: Is the four-eyes principle always necessary for the Audit Trail Review? Production and QA review, or QA review and the releasing person?

问题 14:审计追踪审核是否始终需要四眼原则?生产与 QA 审核,还是 QA 审核与放行人员?

The audit trail review is normally carried out by one person; a second member of staff to check the reviewer does not have to be involved in the review. For example, a member of production reviews the audit trail of the production data; the same applies analogously in quality control. Involvement of Quality Assurance (QA) is not required. The documentation of the audit trail review (completed and assessed checklist) is forwarded to the Qualified Person (QP), who reviews the result in relation to batch release.

审计追踪审核通常由一人执行;无需第二名员工来检查审核人。例如,生产部门的一名成员审核生产数据的审计追踪;质量控制领域同样如此。不需要质量保证(QA)参与。审计追踪审核的记录(已完成并评估的检查清单)转交给 Qualified Person(QP),由其结合批放行审核该结果。

Question 15: Which person, in which role, usually carries out the double-check – that is, the substantive review of the Audit Trail Review performed?

问题 15:通常由哪个人、以何种角色执行复核——即对所执行的审计追踪审核进行实质性审查?

The audit trail review is a review of the changes/additions made after the initial data entry. It is not necessary for another person to check this review again. The substantive review of the audit trail must in any case be ensured; that is, the reviewer must in all cases have a sound knowledge of the relevant process. A purely formal ATR is not permissible. To clarify: only one person with appropriate expertise is needed to carry out the ATR.

审计追踪审核是对初始数据录入之后所做变更/增补的审核。不需要另一人再次检查该审核。无论如何必须确保对审计追踪进行实质性审查;也就是说,审核人在所有情况下都必须对相关工艺有扎实的知识。纯粹形式化的 ATR 是不允许的。需要澄清的是:执行 ATR 只需要一名具备相应专业知识的人员。

Question 16: Does QA not also come into play in the review, as a check that the review has been performed?

问题 16:QA 是否也应在审核中发挥作用,以检查审核是否已执行?

As part of its regular self-inspections, the Quality Assurance department should check that the audit trails of all manufactured batches have been reviewed for deviations/changes.

作为其定期自检的一部分,质量保证部门应检查所有已生产批次的审计追踪是否已针对偏差/变更进行了审核。

Question 17: If the system does not offer the option of entering a comment when an operator changes a parameter, how can this problem be solved?

问题 17:如果系统在操作员更改参数时未提供输入注释的选项,如何解决该问题?

If an electronic system does not allow entries relating to parameter changes, documentation must be made manually on paper. This documentation must then be reviewed together with the rest of the – where applicable electronic – batch record.

如果电子系统不允许录入与参数变更相关的信息,则必须手动在纸质文件上记录。随后,该记录必须与其余批记录(在适用情况下为电子批记录)一并审核。

Question 18: Must adjustments and/or repairs to the underlying SQL database, carried out by the manufacturer, be captured in the Audit Trail? By analogy with repairs to equipment, which are entered in the logbook.

问题 18:由制造商对底层 SQL 数据库进行的调整和/或修复,是否必须记录在审计追踪中?参照设备维修记录在日志中的做法。

For programming work/changes/updates/patches to a database, the change control process must be applied; it is irrelevant who carries out these changes. An entry in the audit trail is not required.

对于数据库的编程工作/变更/更新/补丁,必须应用变更控制流程;由谁执行这些变更无关紧要。不需要在审计追踪中录入。

Question 19: If set point changes are foreseen in the batch record and are also verified there by means of double-checking, can the Audit Trail Review in a process control system be omitted on a risk basis for this purpose?

对于数据库的编程工作/变更/更新/补丁,必须应用变更控制流程;由谁执行这些变更无关紧要。不需要在审计追踪中录入。

No. Changes – even if they are foreseen – should be traceably documented, and the audit trail is the appropriate tool for this.

不可以。变更——即使已预见——也应可追溯地记录,而审计追踪是为此目的合适的工具。

Question 20: If the ATR is reviewed electronically, can the result then be documented on paper? Or should this also be done electronically?

问题 20:如果 ATR 以电子方式审核,结果能否记录在纸质文件上?还是也应以电子方式记录?

To avoid a hybrid solution, the result should also be documented electronically. Documentation on paper should be avoided, but is not prohibited.

为避免混合式方案,结果也应以电子方式记录。应避免纸质记录,但纸质记录并未被禁止。

原文来自GMP Journal网站,点击阅读原文可查看原文。

#计算机化系统 #数据可靠性 #审计追踪

来源:GMP干货 · mp.weixin.qq.com